ERVH48-1 (Gene)

Organism:

Homo sapiens

Taxonomy (Entity type)

Gene:

ERVH48-1 associations

Collection (Entity type)

Id:ENSG00000233056

Entrez:90625

Ensembl:ENSG00000233056

Description:endogenous retrovirus group 48 member 1, envelope

Many different endogenous retrovirus families are expressed in normal placental tissue at high levels, suggesting that endogenous retroviruses are functionally important in reproduction. This gene is part of an endogenous retrovirus provirus that has placenta specific expression. The protein encoded has the characteristics of a retroviral envelope protein but is truncated and lacks the transmembrane domain. The protein inhibits cell fusion by competing with syncytin-1 for binding to a cell receptor. [provided by RefSeq, May 2015]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ERVH48-1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ERVH48-1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ERVH48-1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ERVH48-1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ERVH48-1.

Results found

Linked to

	Label	Description
	GSE146687 2 V 5 ERIBULIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE228017 parthenolide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 7 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172458 0 V 1 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE171180,GSE171181 0 V 1 E7107 HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE235066 4 V 0 CISPLATIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE212330 1 V 0 AZACITIDINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE228017 0 V 1 PARTHENOLIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE211151 1 V 0 PROGESTERONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE146687 2 V 5 ERIBULIN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE228017 parthenolide 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 7 v 11 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE172458 0 V 1 CISPLATIN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE171180,GSE171181 0 V 1 E7107 HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE235066 4 V 0 CISPLATIN HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE212330 1 V 0 AZACITIDINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE228017 0 V 1 PARTHENOLIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE211151 1 V 0 PROGESTERONE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.